Chien-Shing Chen

Exosome removal as a therapeutic adjuvant in cancer

Annette M. Marleau, Chien-Shing Chen, James A. Joyce et al. · Journal of Translational Medicine · 2012 · 420 citations · Full text

Medicine, Oncology, Pharmacology +16

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo

Zheng‐Wei Lee, Jianbiao Zhou, Chien-Shing Chen et al. · PLoS ONE · 2011 · 382 citations · Full text

Medicine, Oncology, Pharmacology +7

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford et al. · Blood · 2007 · 264 citations · Full text

Medicine, Hematology, Immunology +15

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 162 citations · Full text

Medicine, Cancer Biology, Oncology +9

Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies

Chiung‐Ing Wong, Tong-San Koh, Ross A. Soo et al. · Journal of Clinical Oncology · 2009 · 83 citations · Full text

Pharmacy, Oncology, Pharmacology +17